Literature DB >> 26618196

Caveolae-mediated Delivery of Therapeutic Nanoparticles across Blood-endothelial Barrier.

Zhenjia Wang1.   

Abstract

Entities:  

Keywords:  Caveolae; Caveolae-mediated Transcytosis; Endothelial Barrier; Therapeutic Nanoparticles

Year:  2014        PMID： 26618196      PMCID： PMC4662261     

Source DB:  PubMed          Journal:  Austin J Anal Pharm Chem


× No keyword cloud information.
  16 in total

1.  Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway.

Authors:  C Tiruppathi; W Song; M Bergenfeldt; P Sass; A B Malik
Journal:  J Biol Chem       Date:  1997-10-10       Impact factor: 5.157

Review 2.  The multiple faces of caveolae.

Authors:  Robert G Parton; Kai Simons
Journal:  Nat Rev Mol Cell Biol       Date:  2007-03       Impact factor: 94.444

3.  Controlled drug delivery systems: past forward and future back.

Authors:  Kinam Park
Journal:  J Control Release       Date:  2014-04-30       Impact factor: 9.776

4.  Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER.

Authors:  L Pelkmans; J Kartenbeck; A Helenius
Journal:  Nat Cell Biol       Date:  2001-05       Impact factor: 28.824

5.  Nanoparticles squeezing across the blood-endothelial barrier via caveolae.

Authors:  Zhenjia Wang; Asrar B Malik
Journal:  Ther Deliv       Date:  2013-02

Review 6.  Caveolin regulation of endothelial function.

Authors:  Richard D Minshall; William C Sessa; Radu V Stan; Richard G W Anderson; Asrar B Malik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-12       Impact factor: 5.464

7.  Application of nanotechnology in cancer therapy and imaging.

Authors:  Xu Wang; Lily Yang; Zhuo Georgia Chen; Dong M Shin
Journal:  CA Cancer J Clin       Date:  2008-01-28       Impact factor: 508.702

8.  Size and dynamics of caveolae studied using nanoparticles in living endothelial cells.

Authors:  Zhenjia Wang; Chinnaswamy Tiruppathi; Richard D Minshall; Asrar B Malik
Journal:  ACS Nano       Date:  2009-12-22       Impact factor: 15.881

9.  Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils.

Authors:  Zhenjia Wang; Jing Li; Jaehyung Cho; Asrar B Malik
Journal:  Nat Nanotechnol       Date:  2014-02-23       Impact factor: 39.213

10.  Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors.

Authors:  Hemant Sarin; Ariel S Kanevsky; Haitao Wu; Alioscka A Sousa; Colin M Wilson; Maria A Aronova; Gary L Griffiths; Richard D Leapman; Howard Q Vo
Journal:  J Transl Med       Date:  2009-06-23       Impact factor: 5.531
View more
  4 in total

Review 1.  Neurotheranostics as personalized medicines.

Authors:  Bhavesh D Kevadiya; Brendan M Ottemann; Midhun Ben Thomas; Insiya Mukadam; Saumya Nigam; JoEllyn McMillan; Santhi Gorantla; Tatiana K Bronich; Benson Edagwa; Howard E Gendelman
Journal:  Adv Drug Deliv Rev       Date:  2018-10-26       Impact factor: 15.470

Review 2.  Imaging Nanotherapeutics in Inflamed Vasculature by Intravital Microscopy.

Authors:  Zhenjia Wang
Journal:  Theranostics       Date:  2016-10-08       Impact factor: 11.556

Review 3.  Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites.

Authors:  Xinyue Dong; Dafeng Chu; Zhenjia Wang
Journal:  Theranostics       Date:  2017-01-25       Impact factor: 11.556

Review 4.  Role of Nanotechnology and Their Perspectives in the Treatment of Kidney Diseases.

Authors:  J P Jose Merlin; Xiaogang Li
Journal:  Front Genet       Date:  2022-01-05       Impact factor: 4.599
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.